Abstract 13656: Outcomes of Vaccine Preventable Diseases and Heart Failure With Reduced Ejection Fraction

BackgroundOver five million Americans suffer from Heart Failure (HF), and this is associated with multiple chronic comorbidities and recurrent decompensations. Currently, there is an increased incidence of vaccine-preventable diseases (VPDs). We aim to investigate the impact of VPDs on hospitalizati...

Full description

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) N.Y.), 2021-11, Vol.144 (Suppl_1), p.A13656-A13656
Main Authors: Del Cid Fratti, Juan Daniel, Argueta, Erwin
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BackgroundOver five million Americans suffer from Heart Failure (HF), and this is associated with multiple chronic comorbidities and recurrent decompensations. Currently, there is an increased incidence of vaccine-preventable diseases (VPDs). We aim to investigate the impact of VPDs on hospitalization outcomes in patients with heart failure with reduced ejection fraction (HFrEF). MethodsA retrospective analysis from all hospital admissions from the 2016-2018 National Inpatient Sample (NIS) using the ICD-10CM codes for patients admitted with a primary diagnosis of VPDs with HFrEF and those without reduced ejection fraction. Outcomes evaluated were in-hospital mortality, length of stay (LOS), health care utilization, frequency of admissions, and in-hospital complications. Multivariate regression analysis was conducted to adjust for confounders. ResultsOut of 317,670 VPDs discharges, we identified 12,130 (3.8%) patients with HFrEF as comorbidity. The most common admission diagnosis for VPDs was influenza virus (IV) infection (75.0% vs 64.1%; P:
ISSN:0009-7322
1524-4539
DOI:10.1161/circ.144.suppl_1.13656